Treatment with Dimethyl Fumarate Enhances Cholinergic Transmission in Multiple Sclerosis.
Carolina Gabri NicolettiDoriana LandiFabrizia MonteleoneGiorgia MataluniMaria AlbaneseBenedetta LaurettiCamilla RocchiIlaria SimonelliLaura BoffaFabio ButtariNicola Biagio MercuriDiego CentonzeGirolama Alessandra MarfiaPublished in: CNS drugs (2020)
Treatment of MS patients with DMF results in increased cholinergic stimulation, with possible implications for neuroinflammation and neuroprotection.